Hashimoto’s disease is the most common cause of hypothyroidism in children and adolescents, yet it remains frequently overlooked, particularly in adolescent girls. Fatigue, mood changes, weight gain, and cognitive slowing are often attributed to mental health conditions or dismissed as normal features of puberty, delaying diagnosis and treatment. This pattern reflects a broader failure to recognize how autoimmune thyroid disease presents during adolescence, and how gendered assumptions shape clinical interpretation of symptoms at a critical stage of physical and psychological development.

Autoimmune thyroid disease often emerges quietly during adolescence, a period already marked by profound hormonal, physical, and emotional change. In girls, symptoms may unfold gradually: persistent fatigue, cold intolerance, declining academic performance, changes in weight, menstrual irregularities, or mood disturbances. Rather than prompting endocrine evaluation, these concerns are frequently explained away as stress, anxiety, depression, or the expected turbulence of teenage life. The result is not simply a missed diagnosis, but months or years during which a treatable condition remains unaddressed, complicating the management of hypothyroidism in children and adolescents.

Diagnostic overshadowing in adolescent girls

Adolescent girls are uniquely vulnerable to diagnostic overshadowing. The overlap between thyroid dysfunction and common mental health presentations creates fertile ground for misattribution, particularly in a clinical culture that often interprets girls’ symptoms through a psychosocial lens. Complaints of exhaustion may be framed as burnout or low motivation; cognitive slowing as inattention; weight gain as behavioral failure. When symptoms persist despite reassurance or mental health intervention, the underlying cause is too often reconsidered late, if at all, reflecting broader sex differences in pediatric diagnosis and care.

The consequences of delayed recognition extend beyond laboratory abnormalities. Untreated hypothyroidism during adolescence can affect growth, pubertal development, academic functioning, and psychological well-being. For girls, whose identities and self-esteem are already under pressure, prolonged symptoms can reinforce stigma and self-blame. Being told repeatedly that nothing is “wrong enough” to explain how they feel may erode trust in medical care and normalize suffering during a formative stage of development, exacerbating the impact of thyroid disease in children and adolescents.

Laboratory interpretation and dynamic physiology

Laboratory interpretation plays a central role in this delay. Early autoimmune thyroid disease does not always present with overt hypothyroidism. Thyroid-stimulating hormone levels may be normal or only mildly elevated, fluctuating as autoimmune activity evolves. Thyroid antibodies (often present before biochemical dysfunction becomes clear) are not routinely assessed in adolescents with nonspecific symptoms. When testing is limited to a single “normal” value, clinicians may offer false reassurance rather than longitudinal monitoring, missing an opportunity for earlier recognition of autoimmune thyroid disease in children.

This reliance on reference ranges over clinical context is particularly problematic in adolescents, whose physiology is dynamic rather than static. Puberty alters hormone metabolism, immune activity, and symptom expression. A normal laboratory result at one point in time does not preclude evolving disease, especially when symptoms persist or worsen. Yet follow-up is often deferred, and ongoing concerns are redirected elsewhere, ignoring the complex relationship between puberty and immune function.

The need for clinical curiosity

The issue is not one of aggressive screening or overdiagnosis, but of clinical curiosity. When an adolescent girl presents repeatedly with fatigue, mood changes, cognitive complaints, or unexplained weight gain, it warrants reconsideration of the differential diagnosis. When symptoms do not improve with initial interventions, it should prompt clinicians to ask not only what else could be done, but what else could be missed.

Mental health care is essential and lifesaving for many adolescents, but it should not become a default explanation that closes diagnostic inquiry. Autoimmune disease and mental health conditions are not mutually exclusive, and one does not preclude the other. Framing symptoms as psychological without sufficient medical evaluation risks delaying appropriate treatment while reinforcing harmful narratives about adolescent girls’ bodies and experiences, leading to physical illness misdiagnosed as mental health conditions.

Hashimoto’s disease in adolescent girls is not rare, dramatic, or difficult to identify once considered. It is quiet, gradual, and easily overlooked, hidden not by lack of evidence, but by assumptions about what teenage girls are expected to feel. Recognition does not require advanced testing or specialized technology. It requires attentiveness, longitudinal thinking, and a willingness to revisit initial conclusions when the clinical picture does not align with reassurance.

Adolescence is a critical window for intervention, not only to address disease progression but to establish trust in medical care. When clinicians take girls’ symptoms seriously (when they look beyond surface explanations and remain open to evolving diagnoses) they affirm that suffering is not an expected rite of passage. Hashimoto’s disease in adolescent girls has long been present in clinical practice. The challenge is learning to see what has been there all along.

Callia Georgoulis is a health writer.